VIRTUALRadiotheranosticsSummitExpanding Access to Targeted Cancer
Care Across Africa
Expanding Access to Targeted Cancer
Care Across Africa
In collaboration with Medicaid Cancer Foundation
Watch the seriesRadiotheranostics is advancing rapidly, offering new hope for cancer patients by combining molecular imaging with targeted radiation to precisely detect and treat tumors. By using a single molecule to both visualize and treat cancer, it eliminates the trial-and-error approach of traditional oncology and spares healthy tissue from unnecessary damage.
For nations, investing in this field isn’t just about advancing science—it means strengthening a key pillar of modern, personalized medicine and improving patient survival. The Virtual Radiotheranostics Summit, organized by the Oncidium foundation in collaboration with Medicaid Cancer Foundation. Across three one-hour sessions, participants will attend webinars covering the science of radiotheranostics, the practical pathway to implementation in Nigeria, and lessons from global experts.
Whether you are an oncologist, nuclear medicine professional, hospital leader, policymaker or investor, this summit is your entry point into one of the most promising frontiers in cancer care, and a call to action for equitable access.
Concept
& Landscape
Infrastructure
& Technology
GLOBAL
Experience
Case StudIES
Program
Dr. Akintunde Orunmuyi
Nuclear Medicine Department, University Hospital Southampton NHS Foundation Trust.The Oncidium foundation ambassador.
Dr. Mayowa Kolade
Nuclear Medicine Consultant, Molecular Imaging & Theranostics Specialist
Key Topics:
- Introduction to radiotheranostics and its role in precision medicine
- Mechanisms of targeting (ligands, receptors, radiotracers)
- Diagnostic–therapeutic pairing and treatment workflows
- Clinical applications (e.g., prostate cancer, neuroendocrine cancers)
- Safety, dosimetry, and patient selection
- Overview of the global landscape and emerging therapies
- Relevance to Nigeria’s cancer burden and care pathways
Iyobosa B. Uwadiae - Moderator
Educator | Medical Physicist | Grief Educator | President, Nigerian Association of Medical Physicists (NAMP)|
Dr. Mahipal Rathod, PharmD, RPh, BCNP
The Ohio State University – Wexner Medical Center | OSUCCC–James | Solove Research Institute; Assistant Director, Nuclear Pharmacy; Chair, University Radiation Safety Committee (Medical Use & Crisis/Monitoring Sub-Committees); Vice Chair, Audit Subcommittee; APhA – Nuclear Pharmacy SIG & Nuclear Pharmacy Education Committee; Board of Pharmacy Specialties – Vice Chair, Nuclear Pharmacy Specialty Council; Member, BCNP Exam Standard Setting Panel; SNMMI – Clinical Trials Network, Therapy Clinical Trials Network, Radiopharmaceutical Sciences Advisory Committee
Key Topics:
- Evolution of radiotheranostics globally
- Lessons from successful implementation in different healthcare systems
- Common challenges and how to overcome them
- Future directions in the field (emerging therapies, technologies)
- Opportunities for Nigeria and the broader African region
- Building sustainable, locally led programmes
Dr. Iyobosa B. Uwadiae - Moderator
Educator | Medical Physicist | Grief Educator | President, Nigerian Association of Medical Physicists (NAMP)|
Wed, 26 Aug 2026, 12 - 1 PM
Prof. Musa Ali-Gombe
Director of Clinical Services, National Institute for Cancer Research and
Treatment (NICRAT).
Dr. Akintunde Orunmuyi
Nuclear Medicine Department, University Hospital Southampton NHS Foundation Trust.The Oncidium foundation ambassador.
Prof. Abidemi Omonisi
President/CEO
Nigerian Cancer Society
Dr. Samuel Nguku
Head of Theranostics Program at AKUHN - Aga Khan University Hospital, Nairobi
Dr. Mahipal Rathod, PharmD, RPh, BCNP
The Ohio State University – Wexner Medical Center | OSUCCC–James | Solove Research Institute; Assistant Director, Nuclear Pharmacy; Chair, University Radiation Safety Committee (Medical Use & Crisis/Monitoring Sub-Committees); Vice Chair, Audit Subcommittee; APhA – Nuclear Pharmacy SIG & Nuclear Pharmacy Education Committee; Board of Pharmacy Specialties – Vice Chair, Nuclear Pharmacy Specialty Council; Member, BCNP Exam Standard Setting Panel; SNMMI – Clinical Trials Network, Therapy Clinical Trials Network, Radiopharmaceutical Sciences Advisory Committee
Dr. Zainab Shinkafi-Bagudu
CEO, Medicaid Cancer Foundation
UICC President-Elect
Key Topics:
- Current state of nuclear medicine in Nigeria
- Infrastructure requirements:
- Imaging systems (PET/CT, SPECT)
- Radiopharmacy and isotope supply chains
- Radiation safety and waste management
- Workforce development:
- Training needs for physicians, physicists, pharmacists, and technologists
- Regulatory and policy considerations
- Barriers to access (cost, reimbursement, logistics, workforce gaps)
- Implementation strategies:
- Pilot centres and phased scale-up
- Public–private partnerships
- Regional centres of excellence
- International collaboration opportunities
- Measuring clinical and economic impact
Dr. Iyobosa B. Uwadiae - Moderator
Educator | Medical Physicist | Grief Educator | President, Nigerian Association of Medical Physicists (NAMP)|
webinars
Webinar 1 The Science of Radiotheranostics
Webinar 2The Global Perspective
Webinar 3 Infrastructure, Training, and Implementation in Nigeria
General Information
The first Virtual Radiotheranostics Summit, hosted by the Oncidium Foundation and Medicaid Cancer Foundation, explores how Nigeria can turn scientific promise into patient access. Three one-hour webinars cover the science of radiotheranostics, the practical pathway to implementation in Nigeria, and lessons from global experts. For clinicians, policymakers, and everyone working toward equitable access to advanced cancer care.
Register Today!
The Oncidium foundation
The Oncidium Foundation is a dedicated nonprofit organization committed to advancing nuclear medicine therapies for cancer care worldwide. Our primary mission revolves around education, awareness, and support for individuals facing the daily battle against cancer, with a focus on those in need of access to the best possible care.
Through our initiatives and the groundbreaking RLT-Connect platform, we aim to bridge these gaps and provide financial support to patients in underserved regions, ensuring they receive the best possible cancer care. Our dedication to this cause drives us to continue raising awareness, educating, and advocating for equitable access to cutting-edge treatments that offer hope and a chance at longer, better lives for cancer patients worldwide.
OFFICIAL Partner
Oncidium Corporate Sponsors
Contact us
Headquarters
The Oncidium foundation
Rue du Bosquet, 15A
1435 Mont-Saint-Guibert
Belgium